Date | Price Target | Rating | Analyst |
---|---|---|---|
8/23/2024 | $11.00 | Buy | B. Riley Securities |
6/5/2024 | $12.00 | Overweight | KeyBanc Capital Markets |
11/30/2023 | $10.00 | Buy | Craig Hallum |
7/21/2023 | $7.00 | Overweight | Cantor Fitzgerald |
7/3/2023 | $9.00 | Buy | H.C. Wainwright |
3/10/2022 | $14.00 | Buy | Colliers Securities |
10/4/2021 | $16.00 | Buy | B. Riley Securities |
SC 13G/A - LifeMD, Inc. (0000948320) (Subject)
SC 13G - LifeMD, Inc. (0000948320) (Subject)
SC 13G - LifeMD, Inc. (0000948320) (Subject)
NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, is set to join the broad-market Russell 3000® Index at the conclusion of the 2024 Russell U.S. Indexes annual reconstitution, effective at the open of U.S. equity markets on Monday, July 1st, according to a preliminary list of additions posted Friday, May 24th. The annual Russell U.S. Indexes reconstitution captures the 4,000 largest U.S. stocks as of Tuesday, April 30th, ranking them by total market capitalization. Membership in the U.S. all-cap Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Ind
NEW YORK, April 29, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced the appointment of Calum MacRae, M.D., Ph.D., a clinician, researcher and educator at Harvard Medical School, as an independent member of its Board of Directors. "We are delighted to welcome Dr. MacRae to the LifeMD Board of Directors. He brings deep experience in cardiology, internal medicine and clinical innovation, with a focus on disease management and the implementation of novel solutions to improve the delivery of virtual healthcare services," said Justin Schreiber, Chairman and Chief Executive Officer of LifeMD. "Aside from being a world-reno
NEW YORK, June 20, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced the appointment of William (Will) J. Febbo, Chief Executive Officer and Director of OptimizeRx Corporation (NASDAQ:OPRX) to its Board of Directors. OptimizeRx is a leading provider of digital point-of-care technology solutions that help patients start and stay on therapy. "We are extremely pleased to welcome Will to our Board. He brings to LifeMD a depth of experience in building and managing healthcare companies, and pioneering technology to improve the experience for healthcare providers and patients," said Justin Schreiber, Chairman and Chief Exec
424B3 - LifeMD, Inc. (0000948320) (Filer)
10-Q - LifeMD, Inc. (0000948320) (Filer)
EFFECT - LifeMD, Inc. (0000948320) (Filer)
B. Riley Securities resumed coverage of LifeMD with a rating of Buy and set a new price target of $11.00
KeyBanc Capital Markets initiated coverage of LifeMD with a rating of Overweight and set a new price target of $12.00
Craig Hallum initiated coverage of LifeMD with a rating of Buy and set a new price target of $10.00
4 - LifeMD, Inc. (0000948320) (Issuer)
4 - LifeMD, Inc. (0000948320) (Issuer)
4 - LifeMD, Inc. (0000948320) (Issuer)
Keybanc analyst Scott Schoenhaus maintains LifeMD (NASDAQ:LFMD) with a Overweight and lowers the price target from $12 to $10.
LifeMD, Inc. (NASDAQ:LFMD) today announced the launch of private health insurance acceptance for its virtual primary care services, including weight management for medically qualified patients. Initially available in select states, the company plans to continue enrollments with private payors to facilitate access to medically necessary services, ultimately having broad coverage options across all 50 states. As part of its early 2025 roadmap, LifeMD expects to begin accepting Medicare.
Gainers Entero Therapeutics (NASDAQ:ENTO) stock rose 10.2% to $2.6 during Monday's after-market session. The market value of their outstanding shares is at $7.1 million. Akanda (NASDAQ:AKAN) stock rose 7.74% to $2.92. The company's market cap stands at $5.5 million. LifeMD (NASDAQ:LFMD) stock rose 5.81% to $8.0. The market value of their outstanding shares is at $327.0 million. Purple Biotech (NASDAQ:PPBT) shares rose 5.79% to $0.58. The company's market cap stands at $15.2 million. Salarius Pharmaceuticals (NASDAQ:SLRX) shares rose 5.29% to $0.44. The market value of their outstanding shares is at $2.0 million. Compass Therapeutics (NASDAQ:CMPX) shares increased by 4.95% to $1.27. The
NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of September: H.C. Wainwright 26th Annual Global Investment Conference, September 9-11 at the Lotte New York Palace Hotel. Management will deliver a corporate presentation on Monday, September 9th at 12:00 p.m. Eastern time and will hold one-on-one meetings with investors.TD Cowen 9th Annual FutureHealth Conference, September 10 at One Vanderbilt in New York City. Management will participate in a panel discussion on Tuesday, September 10th at 2:20 p.m. Easter
Revenue increased 41% year-over-year to $50.7 million with telehealth revenue up 67%Telehealth achieved standalone profitability one quarter ahead of guidance, with adjusted EBITDA of $820,000Weight management subscribers exceeded 60,000 as of June 30, 2024Adjusted EBITDA increased 44% to $2.5 millionCash of $35.7 million as of June 30, 2024, and positive net cash flow in three of the last four quarters Conference call begins at 4:30 p.m. Eastern time today NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today reported financial results for the three and six months ended June 30, 2024. Management Commentary "L
Medifast (NYSE:MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, today reported results for the second quarter ended June 30, 2024. Second Quarter 2024 Revenue of $168.6 million, with revenue per active earning Coach of $4,972 Independent active earning OPTAVIA Coaches of 33,900 Net loss of $8.2 million (non-GAAP adjusted net income of $10.1 million) Loss per diluted share of $0.75 (non-GAAP adjusted earnings per share ("EPS") of $0.92) Cash, Cash Equivalents, and Investment Securities of $163.5 million with zero debt "We are acting decisively to transform our business to position us for long-term growth, with
Revenue increased 41% year-over-year to $50.7 million with telehealth revenue up 67%Telehealth achieved standalone profitability one quarter ahead of guidance, with adjusted EBITDA of $820,000Weight management subscribers exceeded 60,000 as of June 30, 2024Adjusted EBITDA increased 44% to $2.5 millionCash of $35.7 million as of June 30, 2024, and positive net cash flow in three of the last four quarters Conference call begins at 4:30 p.m. Eastern time today NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today reported financial results for the three and six months ended June 30, 2024. Management Commentary "L
Medifast (NYSE:MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, today reported results for the second quarter ended June 30, 2024. Second Quarter 2024 Revenue of $168.6 million, with revenue per active earning Coach of $4,972 Independent active earning OPTAVIA Coaches of 33,900 Net loss of $8.2 million (non-GAAP adjusted net income of $10.1 million) Loss per diluted share of $0.75 (non-GAAP adjusted earnings per share ("EPS") of $0.92) Cash, Cash Equivalents, and Investment Securities of $163.5 million with zero debt "We are acting decisively to transform our business to position us for long-term growth, with
NEW YORK, July 30, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and six months ended June 30, 2024 after the close of the U.S. financial markets on August 7, 2024 and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date:Wednesday, August 7thTime:4:30 p.m. Eastern timeToll-Free Dial-In:1-800-245-3047International Dial-In:1-203-518-9765Conference ID:LIFEMDLive & Archived Webcast:Link About LifeMD, Inc.LifeMD is a leading provider of virtual primary care. LifeMD offers telemedicine, laboratory and pharmacy services, an